We have tracked over 107 funding programs and $698,092,000 allocated for Influenza Research.
| Recent Funding Opportunity |
|---|
| Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed) (apply for RFA AI 20 003) Funding Number: RFA AI 20 003 Agency: National Institutes of Health Funding Amount: $200,000 |
| Maintenance of Influenza Surveillance Capacity by National Health Authorities Outside the United States. (apply for CDC RFA IP16 160502CONT17) Funding Number: CDC RFA IP16 160502CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Funding Amount: Case Dependent |
| Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (apply for FOR FD 21 006) Funding Number: FOR FD 21 006 Agency: Department of Health and Human Services, Food and Drug Administration Funding Amount: $500,000 |
| Monitoring Cause-specific School Absenteeism for Estimating Community-wide Influenza and SARS-CoV-2 Transmission (apply for RFA CK 21 003) Funding Number: RFA CK 21 003 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Funding Amount: $1,000,000 |
| Quantifying Contact Rates and Mixing Patterns in Workers in Non-healthcare Work Settings in the United States and Modeling the Effect of Workplace Social Distancing Measures in Reducing Influenza Transmission (apply for RFA CK 19 002) Funding Number: RFA CK 19 002 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Funding Amount: $350,000 |
| Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States (apply for CDC RFA IP16 160402CONT17) Funding Number: CDC RFA IP16 160402CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Funding Amount: Case Dependent |
| Influenza and Other Respiratory Diseases in Southern Hemisphere (apply for RFA IP 11 014) Funding Number: RFA IP 11 014 Agency: Centers for Disease Control and Prevention Funding Amount: $1,000,000 |
| Influenza Vaccine Efficacy in Tropical and Developing Countries (apply for RFA IP 11 013) Funding Number: RFA IP 11 013 Agency: Centers for Disease Control and Prevention Funding Amount: $1,250,000 |
| Influenza Transmission Research Consortium (P01 Clinical Trial Optional) (apply for RFA AI 25 035) Funding Number: RFA AI 25 035 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Developing Sustainable Influenza Surveillance Networks and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States (apply for CDC RFA IP09 906) Funding Number: CDC RFA IP09 906 Agency: Centers for Disease Control and Prevention Funding Amount: $1,500,000 |
| Household Transmission of Influenza Viruses in the Community (apply for RFA IP 17 001) Funding Number: RFA IP 17 001 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Funding Amount: $500,000 |
| Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in a Malaria Endemic Area of Malawi with High HIV Prevalence (apply for RFA IP 14 002) Funding Number: RFA IP 14 002 Agency: Centers for Disease Control and Prevention Funding Amount: $1,200,000 |
| Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed) (apply for RFA AI 23 056) Funding Number: RFA AI 23 056 Agency: National Institutes of Health Funding Amount: $750,000 |
| Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory Pathogens in South Africa (apply for RFA IP 21 003) Funding Number: RFA IP 21 003 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Funding Amount: $1,250,000 |
| Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed) (apply for RFA AI 22 020) Funding Number: RFA AI 22 020 Agency: National Institutes of Health Funding Amount: $500,000 |
| Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Influenza in the United States (apply for RFA IP 11 003) Funding Number: RFA IP 11 003 Agency: Centers for Disease Control and Prevention Funding Amount: $785,000 |
| Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization (apply for CDC RFA IP21 2102) Funding Number: CDC RFA IP21 2102 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Funding Amount: Case Dependent |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States (apply for CDC RFA IP13 130605CONT17) Funding Number: CDC RFA IP13 130605CONT17 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention Funding Amount: Case Dependent |
| Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization. (apply for CDC RFA IP16 160702CONT17) Funding Number: CDC RFA IP16 160702CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Funding Amount: Case Dependent |
| Systems Approach to Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed) (apply for RFA AI 21 017) Funding Number: RFA AI 21 017 Agency: National Institutes of Health Funding Amount: Case Dependent |
| Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region (apply for RFA IP 13 002) Funding Number: RFA IP 13 002 Agency: Centers for Disease Control and Prevention Funding Amount: $1,000,000 |
| Centers for Disease Control and Prevention US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations (apply for RFA IP 15 00203CONT17) Funding Number: RFA IP 15 00203CONT17 Agency: Centers for Disease Control and Prevention - ERA Funding Amount: Case Dependent |
| Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic Influenza by National Health Authorities outside the United States (apply for CDC RFA IP11 1103) Funding Number: CDC RFA IP11 1103 Agency: Centers for Disease Control and Prevention Funding Amount: $500,000 |
| Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trials Not Allowed (apply for RFA FD 21 033) Funding Number: RFA FD 21 033 Agency: Department of Health and Human Services, Food and Drug Administration Funding Amount: $500,000 |
| Establish Adjuvant Hub to Enable Adjuvanted Influenza Vaccines in Under Resourced Nations (apply for EP IDS 14 002) Funding Number: EP IDS 14 002 Agency: Assistant Secretary for Preparedness and Response Funding Amount: $4,000,000 |
Inside USGrants.org Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads